CervoMed Inc. Deferred Tax Liabilities, Other Finite-Lived Assets
CervoMed Inc. (CRVO) had Deferred Tax Liabilities, Other Finite-Lived Assets of $2.27 million as of 2014-12-31, per its 10-K filed 2015-04-03.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets · last filed 2015-04-03
- 2014-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $2.27M.
- 2013-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $3.00M.
| Period end | Deferred Tax Liabilities, Other Finite-Lived Assets |
|---|---|
| 2014-12-31 | $2.27M 10-K · filed 2015-04-03 |
| 2013-12-31 | $3.00M 10-K · filed 2015-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |